NCT00949715

Optimize RV Follow-up Selective Site Pacing Clinical Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 67 (actual)
• Sponsor: Medtronic Cardiac Rhythm and Heart Failure · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the Optimize RV Follow-Up study is to determine the long-term effect of selective site pacing. Selective site pacing refers to which area of the right ventricle the lead is placed. The goal of selective site pacing is to improve how the heart contracts when paced.

Detailed description

The Optimize RV Follow-Up Selective Site Pacing Clinical Trial is open to subjects that were previously enrolled in the Optimize RV Selective Site Pacing Clinical Trial.

Conditions

• Cardiac Pacing
• Right Ventricular Pacing
• Left Ventricular Ejection Fraction

Interventions

Type	Name	Description
DEVICE	Medtronic or Vitatron Dual-Chamber Pacemaker	A Medtronic or Vitatron market-approved dual-chamber implantable pulse generator (IPG) with atrial tachycardia/atrial fibrillation (AT/AF) trending ability
DEVICE	Medtronic SelectSecure 3830 Lead	Medtronic market-approved SelectSecure Model 3830 bipolar pacing lead

Timeline

• Start date: 2009-09-01
• Primary completion: 2011-04-01
• Completion: 2011-12-01
• First posted: 2009-07-30
• Last updated: 2018-02-15
• Results posted: 2013-10-01

Locations

12 sites across 3 countries: United States, Israel, Italy